REQUEST A DEMO
Total
USD $0.00
Search more companies

BITRIAL Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: BITRIAL Kft. Profile Updated: February 03, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

BiTrial Kft. is a contract research organization specializing in clinical trial expertise for pharmaceutical and medical device companies. They offer project management, clinical monitoring, scientific and health support, patient recruitment, data management, and drug safety services. With a focus on medical devices, they have completed over 60 examinations in the Central-Eastern European region and have a network of contacts in various medical specialties. The company operates in the healthcare industry and serves the pharmaceutical and medical device segments.

Headquarters
Tallya utca 23.
Budapest; Budapest; Postal Code: 1121

Contact Details: Purchase the BITRIAL Kft. report to view the information.

Website: http://www.bitrial.hu

Basic Information
Total Employees:
Purchase the BITRIAL Kft. report to view the information.
Registered Capital:
Purchase the BITRIAL Kft. report to view the information.
Financial Auditors:
Purchase the BITRIAL Kft. report to view the information.
Incorporation Date:
June 17, 2005
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after BITRIAL Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-13.97%
Total operating revenue
-6.75%
Operating Profit/Loss (EBIT)
-9.5%
EBITDA
-8.94%
Net Profit/Loss for the Period
-7.94%
Total Assets
-2.51%
Total Equity
22.67%
Operating Profit Margin (ROS)
0.77%
Net Profit Margin
1.02%
Return on Equity (ROE)
-6.14%
Quick Ratio
0.81%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?